Insights to Manage and Mitigate Risk
How do you best protect your employees? What is the latest science? How will this impact your supply chain? Exponent has been actively working with clients to answer their most pressing questions to help manage and mitigate risk associated with COVID-19.
Exponent prides itself in being responsive.
ALERT: FDA, VA, and NIH Address the Production and Use of 3D Printed Swabs for COVID-19
On May 15, 2020, the FDA, Department of Veterans Affairs' Innovation Ecosystem, and the National Institutes of Health's (NIH's) 3D Print Exchange held a town hall for researchers, clinical laboratories, and commercial manufacturers to discuss the production and use of 3D printed swabs during the COVID-19 Public Health Emergency.
PUBLICATION: Grain Dust Explosion in a Milling Facility
With facilities currently dormant due to the pandemic, there are several considerations to take before turning industrial equipment back online.
ALERT: Trends in Measured PM2.5 Concentrations in the New York City Metropolitan Area During the COVID-19 Pandemic
Concentrations of pollutants, such as NO2 and fine particulate matter (PM2.5) are often related to emissions associated with human activities such as vehicle traffic and industrial activity. As some of these activities have been reduced during the COVID-19 pandemic, associated emissions have likely been reduced. The question considered here is what, if any, changes in PM2.5 concentrations may have occurred during the pandemic in a major metropolitan area?
ALERT: ASHRAE Issues Guidance on Evaluating Building Systems Before Reopening following COVID-19 Closures
Transmission of Sars-Cov-2 Through the Air Is Sufficiently Likely That Airborne Exposure to the Virus Should Be Controlled
On May 7, 2020, ASHRAE issued a new guidance to assist building owners and decision-makers on how best to reopen their facilities following a closure due to the COVID-19 pandemic.
Recovering Manufacturing from a Line Down or Transfer?
Six Key Contributing Factors to Successfully Bringing Up a Manufacturing Line
There are six key contributing factors to successfully bringing up a manufacturing line. These factors, when addressed properly, have helped manufacturers save millions of dollars.
Why the Coronavirus Will Continue to Shock Global Markets
Risks That Will Need to Be Quickly Discovered and Corrected by Factories That Are Reopening
The microchip and battery industries have been hit particularly hard, and the effects will continue to delay and stall factories’ ability to resume operations.
Are Travel Restrictions to China Delaying Your Product Launch Cycle?
In-Region OEM Support in the Era of the Coronavirus
On-the-ground OEM representatives can support design and manufacturing decisions, including the qualification of new suppliers, supplier audits, inventory management, quality control, and reliability test design.
Force Majeure or Supplier Defect/Contractor Obligation?
Product Supply Chains and Major Construction Projects are Significantly Affected by COVID-19 Outbreak
Reportedly more than 3,000 of force majeure certificates have been issued to Chinese firms since the beginning of February by the China Council for the Promotion of International Trade (CCPIT).
Supply Chain Diversification During COVID-19
Manufacturing with the ASEAN "Mighty Five"
Manufacturers seeking to expand operations into the "Mighty Five" (MITI-V) nations of Malaysia, India, Indonesia, Vietnam, and Thailand should take steps to understand and mitigate the potential risks associated with diversification into the ASEAN regions.
PUBLICATION: Consideration of the Aerosol Transmission for COVID‐19 and Public Health
This article analyzes the available evidence to address airborne, aerosol transmission of the SARS‐CoV‐2, reviewing and presenting three lines of evidence.
Strategies for Supply Management in China during Travel Restrictions
Leveraging Exponent's Local Presence
With China imposing quarantines on foreigners entering from high-risk countries, just as work at some factories is resuming, it may not be advisable to send domestic staff to manage supply-chain issues.
ALERT: FDA Issues Temporary Guidance Regarding Non-Invasive Remote Monitoring Devices
Guidance for Industry and Food and Drug Administrative Staff to Support Patient Monitoring During the Coronavirus Disease (COVID-19) Public Health Emergency
The FDA has issued temporary guidance regarding device or software changes that could support remote patient monitoring during the COVID-19 public health emergency.
Hand Gel Regulatory Requirements
Due to the outbreak of coronavirus in Europe, there is a high demand for human hygiene products in the European market. Before exporting products to Europe, manufacturer should ensure the products are compliant with local regulations and notify/register the products properly.
ALERT: Trends in Global NO2 Emissions in the First Quarter of 2020
NASA Satellite Data Visualization
Recently, NASA published data on NO2 emissions in the atmosphere over China, Italy and the U.S., in January and February 2020. The "significant decrease" in the February NO2 emissions was "at least partly related to the economic slowdown following the outbreak of coronavirus".
Getting Your Head In The Cloud?
Achieving Digital Resilience in the Cloud Era
Organizations that take proactive steps to ensure their cloud-based offerings are robust, scalable, and secure are best positioned to protect employee/customer data and offer a positive user experience during this demand of online services due to COVID-19.
US EPA Emerging Viral Pathogens Guidance Trigger
Though the threat level in the U.S. is currently low, the use of disinfectants is an important step toward limiting the spread of the disease. EPA issued this rapid response to provide pesticide registrants with a pathway toward communication to the public.